Clinical Research Directory
Browse clinical research sites, groups, and studies.
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
Sponsor: Novartis Pharmaceuticals
Summary
The purpose of this extension study is to evaluate maintenance of Hidradenitis Suppurativa Clinical Response (HiSCR response) in either continuous or interrupted therapy (using a randomized withdrawal period) of two dose regimens and to assess long-term efficacy, safety and tolerability of Secukinumab in subjects with moderate to severe hidradenitis suppurativa completing either of the 2 Phase III studies. This is an expanded access trial for the core trials CAIN457M2301 (NCT03713619) and CAIN457M2302 (NCT03713619).
Official title: A Multicenter, Double-blind, Randomized Withdrawal Extension Study of Subcutaneous Secukinumab to Demonstrate Long-term Efficacy, Safety and Tolerability in Subjects With Moderate to Severe Hidradenitis Suppurativa
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
703
Start Date
2020-03-18
Completion Date
2026-07-15
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
secukinumab
secukinumab 300mg every 2 weeks
secukinumab
secukinumab 300mg every 4 weeks
Locations (191)
Northwest Arkansas Center
Rogers, Arkansas, United States
MedDerm Associates
San Diego, California, United States
University Clinical Trials
San Diego, California, United States
Southern California Skin and Laser
Whittier, California, United States
Florida Academic Centers Research and Education LLC
Coral Gables, Florida, United States
University of MiamiHealth System
Miami, Florida, United States
Olympian Clinical Research
Tampa, Florida, United States
University Of South Florida
Tampa, Florida, United States
Advanced Medical Research
Sandy Springs, Georgia, United States
Endeavor Health
Glenview, Illinois, United States
Dundee Dermatology
West Dundee, Illinois, United States
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana, United States
Tufts Medical Center
Boston, Massachusetts, United States
Beth Israel Deaconess Med Center
Boston, Massachusetts, United States
Minnesota Clinical Study Center
New Brighton, Minnesota, United States
MediSearch Clinical Trials
Saint Joseph, Missouri, United States
St Louis U Clinical Trials
St Louis, Missouri, United States
WA Uni School Of Med
St Louis, Missouri, United States
Skin Specialists PC
Omaha, Nebraska, United States
Icahn School Of Med At Mount Sinai
New York, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Wright State University
Fairborn, Ohio, United States
UP Medical Center H System
Pittsburgh, Pennsylvania, United States
Clinical Research Ctr of Carolinas
Charleston, South Carolina, United States
Bellaire Dermatology Associates
Bellaire, Texas, United States
MDRI Baylor University
Dallas, Texas, United States
Austin Inst for Clinical Research
Pflugerville, Texas, United States
Dr. Stephen Miller, MDPA
San Antonio, Texas, United States
Virginia Clinical Research
Norfolk, Virginia, United States
Novartis Investigative Site
CABA, Buenos Aires, Argentina
Novartis Investigative Site
La Plata, Buenos Aires, Argentina
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina
Novartis Investigative Site
Buenos Aires, Argentina
Novartis Investigative Site
Caba, Argentina
Novartis Investigative Site
Capital Federal, Argentina
Novartis Investigative Site
Phillip, Australian Capital Territory, Australia
Novartis Investigative Site
Benowa, Queensland, Australia
Novartis Investigative Site
East Melbourne, Victoria, Australia
Novartis Investigative Site
Linz, Austria
Novartis Investigative Site
Vienna, Austria
Novartis Investigative Site
Brussels, Brussels Capital, Belgium
Novartis Investigative Site
Ghent, Belgium
Novartis Investigative Site
Liège, Belgium
Novartis Investigative Site
Pleven, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Stara Zagora, Bulgaria
Novartis Investigative Site
Barrie, Ontario, Canada
Novartis Investigative Site
London, Ontario, Canada
Novartis Investigative Site
Peterborough, Ontario, Canada
Novartis Investigative Site
Waterloo, Ontario, Canada
Novartis Investigative Site
Barranquilla, Atlántico, Colombia
Novartis Investigative Site
Zagreb, HRV, Croatia
Novartis Investigative Site
Prague, Prague 1, Czechia
Novartis Investigative Site
Jihlava, Czechia
Novartis Investigative Site
Plzen Bory, Czechia
Novartis Investigative Site
Ústí nad Labem, Czechia
Novartis Investigative Site
Limoges, Haute Vienne, France
Novartis Investigative Site
Toulon, Val De Marne, France
Novartis Investigative Site
Antony, France
Novartis Investigative Site
Bordeaux, France
Novartis Investigative Site
Brest, France
Novartis Investigative Site
Créteil, France
Novartis Investigative Site
Lyon, France
Novartis Investigative Site
Martigues, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Nantes, France
Novartis Investigative Site
Nice, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Reims, France
Novartis Investigative Site
Rouen, France
Novartis Investigative Site
Saint-Mandé, France
Novartis Investigative Site
Saint-Priest-en-Jarez, France
Novartis Investigative Site
Toulouse, France
Novartis Investigative Site
Langenau, Baden-Wurttemberg, Germany
Novartis Investigative Site
Munich, Bavaria, Germany
Novartis Investigative Site
Würzburg, Bavaria, Germany
Novartis Investigative Site
Halle, Saxony-Anhalt, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Bielefeld, Germany
Novartis Investigative Site
Bochum, Germany
Novartis Investigative Site
Erlangen, Germany
Novartis Investigative Site
Frankfurt, Germany
Novartis Investigative Site
Hamburg, Germany
Novartis Investigative Site
Heidelberg, Germany
Novartis Investigative Site
Memmingen, Germany
Novartis Investigative Site
München, Germany
Novartis Investigative Site
Münster, Germany
Novartis Investigative Site
Potsdam, Germany
Novartis Investigative Site
Schwerin, Germany
Novartis Investigative Site
Athens, Greece
Novartis Investigative Site
Chaïdári, Greece
Novartis Investigative Site
Thessaloniki, Greece
Novartis Investigative Site
Thessaloniki, Greece
Novartis Investigative Site
Guatemala City, Guatemala
Novartis Investigative Site
Guatemala City, Guatemala
Novartis Investigative Site
Pécs, Baranya, Hungary
Novartis Investigative Site
Debrecen, Hajdu Bihar Megye, Hungary
Novartis Investigative Site
Kaposvár, Hungary
Novartis Investigative Site
Mysore, Karnataka, India
Novartis Investigative Site
Nagpur, Maharashtra, India
Novartis Investigative Site
Nashik, Maharashtra, India
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site
Jerusalem, Israel
Novartis Investigative Site
Petah Tikva, Israel
Novartis Investigative Site
Ramat Gan, Israel
Novartis Investigative Site
Tel Aviv, Israel
Novartis Investigative Site
Ancona, AN, Italy
Novartis Investigative Site
Cona, FE, Italy
Novartis Investigative Site
Florence, FI, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Pisa, PI, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Naples, Italy
Novartis Investigative Site
Nagoya, Aichi-ken, Japan
Novartis Investigative Site
Kisarazu, Chiba, Japan
Novartis Investigative Site
Ginowan, Okinawa, Japan
Novartis Investigative Site
Koshigaya, Saitama, Japan
Novartis Investigative Site
Itabashi-ku, Tokyo, Japan
Novartis Investigative Site
Osaka, Japan
Novartis Investigative Site
Saida, Lebanon
Novartis Investigative Site
Kaunas, LTU, Lithuania
Novartis Investigative Site
Vilnius, Lithuania
Novartis Investigative Site
Kuala Lumpur, Kuala Lumpur, Malaysia
Novartis Investigative Site
George Town, Pulau Pinang, Malaysia
Novartis Investigative Site
Johor Bahru, Malaysia
Novartis Investigative Site
Guadalajara, Jalisco, Mexico
Novartis Investigative Site
Monterrey, Nuevo León, Mexico
Novartis Investigative Site
Amersfroort, Utrecht, Netherlands
Novartis Investigative Site
Las Piñas, Philippines
Novartis Investigative Site
Makati City, Philippines
Novartis Investigative Site
Warsaw, Mazowian, Poland
Novartis Investigative Site
Ossy, Poland
Novartis Investigative Site
Rzeszów, Poland
Novartis Investigative Site
Warsaw, Poland
Novartis Investigative Site
Warsaw, Poland
Novartis Investigative Site
Wroclaw, Poland
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Porto, Portugal
Novartis Investigative Site
Chelyabinsk, Russia
Novartis Investigative Site
Kazan', Russia
Novartis Investigative Site
Krasnodar, Russia
Novartis Investigative Site
Saint Petersburg, Russia
Novartis Investigative Site
Saint Petersburg, Russia
Novartis Investigative Site
Smolensk, Russia
Novartis Investigative Site
Yaroslavl, Russia
Novartis Investigative Site
Singapore, Singapore
Novartis Investigative Site
Singapore, Singapore
Novartis Investigative Site
Banská Bystrica, Slovakia
Novartis Investigative Site
Košice, Slovakia
Novartis Investigative Site
Prešov, Slovakia
Novartis Investigative Site
Raslouw Centurion, Gauteng, South Africa
Novartis Investigative Site
Soweto, Gauteng, South Africa
Novartis Investigative Site
Seoul, Korea, South Korea
Novartis Investigative Site
Seoul, Korea, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Cadiz, Andalusia, Spain
Novartis Investigative Site
Granada, Andalusia, Spain
Novartis Investigative Site
Barcelona, Catalonia, Spain
Novartis Investigative Site
Fuenlabrada, Madrid, Spain
Novartis Investigative Site
Manises, Valencia, Spain
Novartis Investigative Site
Alicante, Spain
Novartis Investigative Site
Barcelona, Spain
Novartis Investigative Site
Las Palmas GC, Spain
Novartis Investigative Site
Madrid, Spain
Novartis Investigative Site
Madrid, Spain
Novartis Investigative Site
Pontevedra, Spain
Novartis Investigative Site
Bern, Switzerland
Novartis Investigative Site
Geneva, Switzerland
Novartis Investigative Site
Lausanne, Switzerland
Novartis Investigative Site
Taipei, Taiwan
Novartis Investigative Site
Taoyuan District, Taiwan
Novartis Investigative Site
Aydin, Efeler, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site
Antalya, Konyaalti, Turkey (Türkiye)
Novartis Investigative Site
Kayseri, Melikgazi, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Pendik, Turkey (Türkiye)
Novartis Investigative Site
Gaziantep, Sehitkamil, Turkey (Türkiye)
Novartis Investigative Site
Exeter, Devon, United Kingdom
Novartis Investigative Site
Dudley, West Midlands, United Kingdom
Novartis Investigative Site
Bradford, West Yorkshire, United Kingdom
Novartis Investigative Site
Leeds, West Yorkshire, United Kingdom
Novartis Investigative Site
Barnsley, United Kingdom
Novartis Investigative Site
Bristol, United Kingdom
Novartis Investigative Site
London, United Kingdom
Novartis Investigative Site
London, United Kingdom
Novartis Investigative Site
Salford, United Kingdom
Novartis Investigative Site
Hanoi, Vietnam
Novartis Investigative Site
Ho Chi Minh City, Vietnam